Is sweating a side effect of Mounjaro?

Does Mounjaro list sweating as a known side effect?

The Mounjaro Summary of Product Characteristics (SmPC), published on the Electronic Medicines Compendium, does not list sweating (hyperhidrosis) as a common or very common side effect in the way it lists nausea, diarrhoea or constipation. The predominant side-effect profile for tirzepatide is gastrointestinal, you can read more about those patterns on the full Mounjaro side effects overview. That said, sweating does appear in the broader reported experience of GLP-1 and dual GIP/GLP-1 receptor agonists, and the NHS tirzepatide medicines page notes that patients should speak to a pharmacist or doctor if they experience symptoms that concern them, even when those symptoms are not on the most prominent lists.

The absence of sweating from the top-frequency list does not mean it cannot happen. Individual responses to any medicine vary considerably, and our guide to side effects of Mounjaro explores the full range of reactions that people report beyond the headline GI complaints. What matters clinically is not the sweating itself but its character: when it occurs, how severe it is, and what accompanies it.

Sweating that arrives shortly after a dose (particularly alongside shakiness, a racing pulse, light-headedness or confusion) needs to be treated differently from a general sense of feeling warmer than usual. The former pattern has a specific, clinically significant explanation covered below.

Could the sweating be a sign of low blood sugar rather than a direct drug effect?

This is the most important question to ask. Tirzepatide lowers blood glucose, and in people taking it alongside insulin or certain other diabetes medicines, the combined effect can sometimes push blood sugar lower than intended. Hypoglycaemia produces a cluster of symptoms that often includes sweating, shakiness, pallor and a rapid heartbeat. If you are on one of these combinations and you notice those signs together, treat the low blood sugar promptly following your prescriber's guidance and contact your clinical team.

Even for people using Mounjaro for weight management without other glucose-lowering medicines, mild dips in blood sugar after eating can occur, this is sometimes called reactive hypoglycaemia. Symptoms typically arise one to three hours after a meal and resolve once you eat something. It is worth keeping a brief note of when the sweating happens: time of day, relation to meals, and relation to your injection day. That information is genuinely useful for your prescriber.

Unusual sweating after eating is sometimes part of a broader pattern of post-meal symptoms on tirzepatide; the guide to Mounjaro side effects after eating covers that territory in more detail.

Are there other reasons sweating might change on Mounjaro?

Weight loss itself (independent of the medicine) can alter how your body regulates temperature. As body composition changes and metabolic rate shifts, some people notice they feel warmer or sweat more easily during the early months of treatment. This is not a drug toxicity; it reflects the body adapting.

Separately, the GI effects of tirzepatide (particularly nausea and vomiting) can trigger the kind of clammy, cold sweat that accompanies feeling unwell. This is the autonomic nervous system responding to nausea, not the medicine acting directly on sweat glands. As GI symptoms typically settle within a few weeks of starting or increasing a dose, any sweat pattern tied to them usually settles too. If you have also noticed unusual burping alongside other GI symptoms, it is worth reading about whether burping is a side effect of Mounjaro, as it shares a similar adjustment-period pattern. The broader GI picture is worth reading about: bloating on Mounjaro and diarrhoea on Mounjaro are common companions during the adjustment period.

Hormonal factors (including perimenopause or menopause) can also produce sweating that coincidentally begins around the time someone starts a new medicine. Attributing every new symptom to the most recent drug is a natural instinct, but your prescriber will want to consider the full picture.

When should you get medical help, and how do you report a side effect?

Contact a healthcare professional promptly if sweating is accompanied by: severe, persistent abdominal pain that radiates to the back (this could indicate pancreatitis, which the MHRA flagged in a Drug Safety Update for GLP-1 medicines in January 2026); chest pain, breathlessness or a rapid irregular pulse; confusion, difficulty speaking or extreme weakness; or signs of an allergic reaction such as swelling of the face, lips or throat.

Call 999 or go to A&E if any of these are severe. For symptoms that are concerning but not immediately dangerous, same-day GP or pharmacist contact is appropriate, do not wait for your next scheduled review.

You can also report any suspected side effect directly to the MHRA via the Yellow Card scheme. This is open to patients as well as clinicians, and reports from people taking the medicine are genuinely valuable for ongoing safety monitoring. You do not need a diagnosis to submit one.

At nume, our prescribers discuss potential side effects as part of every consultation before treatment is approved, and our aftercare team is available seven days a week for questions that arise during treatment. If sweating or any other symptom is worrying you, that is exactly what the aftercare line is for. You can also explore what is involved in starting a consultation with our clinical team.